Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research... Show more
NAGE's Aroon Indicator triggered a bullish signal on June 10, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 140 similar instances where the Aroon Indicator showed a similar pattern. In of the 140 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Moving Average Convergence Divergence (MACD) for NAGE just turned positive on June 02, 2025. Looking at past instances where NAGE's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NAGE advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAGE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
NAGE broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NAGE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.040) is normal, around the industry mean (16.771). P/E Ratio (78.167) is within average values for comparable stocks, (60.276). NAGE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.289). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (10.449) is also within normal values, averaging (262.169).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a developer of proprietary-based ingredient technologies
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JVSIX | 14.90 | 0.12 | +0.81% |
Janus Henderson Small-Mid Cap Value I | |||
PSVKX | 16.13 | 0.09 | +0.56% |
PGIM Quant Solutions Small-Cap Val R4 | |||
PRUZX | 15.44 | 0.02 | +0.13% |
PGIM Jennison Utility Z | |||
VEUPX | 185.21 | 0.11 | +0.06% |
Vanguard European Stock Instl Plus | |||
SMEYX | 15.93 | -0.04 | -0.25% |
Invesco Small Cap Equity Y |
A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with MDGL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then MDGL could also see price increases.
Ticker / NAME | Correlation To NAGE | 1D Price Change % | ||
---|---|---|---|---|
NAGE | 100% | +0.67% | ||
MDGL - NAGE | 39% Loosely correlated | +0.74% | ||
ETNB - NAGE | 33% Loosely correlated | -2.74% | ||
FHTX - NAGE | 33% Loosely correlated | +0.87% | ||
CRBU - NAGE | 33% Loosely correlated | -3.94% | ||
CRSP - NAGE | 33% Poorly correlated | +2.02% | ||
More |